The expression of BMP, integrin, ZEB2 in ovarian high-grade serous carcinoma in relation with lymph node metastasis

被引:1
|
作者
Zirh, Elham Bahador [1 ,2 ]
Kapakli, Elif Tasar [3 ]
Dolgun, Anil [4 ]
Usubutun, Alp [3 ]
Zeybek, Naciye Dilara [2 ]
机构
[1] TOBB Econ & Technol Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Pathol, Ankara, Turkey
[4] RMIT Univ, Dept Math Sci, Melbourne, Vic, Australia
关键词
High-grade ovarian cancer; lymph node metastasis; BMP2; BMP7; integrin alpha 5; integrin beta 1; ZEB2; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; GENE-EXPRESSION; BREAST-CANCER; TGF-BETA; BONE; INHIBITION; PROTEINS; SURVIVAL;
D O I
10.1080/08977194.2022.2099849
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ovarian cancer (OC) is clinically important because it is diagnosed late and has metastasis when it is diagnosed. Mortality risk increases 2.75 times in the presence of lymph node (LN) metastasis. During metastasis, many molecules including BMPs originated from stroma, and tumor cells participate through transcription factors and integrins for cytoskeleton regulation during cell migration. We hypothesized an inverse correlation between BMP2 and BMP7 along with changes in ZEB2, and integrin alpha 5 beta 1 in high-grade OCs in relation to LN metastasis. The BMP2 immunoreactivity was strong along with strong ZEB2 and weak integrins' immunoreactivity in samples with LN metastasis. Strong immunoreactivity of BMP7 was accompanied by strong immunoreactivity of integrins in the samples without LN metastasis. Study results showed BMP2's strong positive immunoreactivity and weak BMP7 immunoreactivity in tumor cells with a significantly weak inverse correlation. This inverse correlation should be considered as both BMPs have different effects in the window of cancer progression and invasion.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 50 条
  • [31] Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients
    He, Jing
    Liu, Yan
    Zhang, Lixia
    Zhang, Hongwei
    MEDICAL SCIENCE MONITOR, 2018, 24 : 8933 - 8940
  • [32] Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
    Tsonis, Orestis
    Gkrozou, Fani
    Vlachos, Konstantinos
    Paschopoulos, Minas
    Mitsis, Michail C.
    Zakynthinakis-Kyriakou, Nikolaos
    Boussios, Stergios
    Pappas-Gogos, George
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [33] Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
    Kim, Se Ik
    Jung, Minsun
    Dan, Kisoon
    Lee, Sungyoung
    Lee, Cheol
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    Han, Dohyun
    Lee, Maria
    CANCERS, 2020, 12 (04)
  • [34] A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma
    Sun, Chao-Yang
    Su, Tie-Fen
    Li, Na
    Zhou, Bo
    Guo, En-Song
    Yang, Zong-Yuan
    Liao, Jing
    Ding, Dong
    Xu, Qin
    Lu, Hao
    Meng, Li
    Wang, Shi-Xuan
    Zhou, Jian-Feng
    Xing, Hui
    Weng, Dan-Hui
    Ma, Ding
    Chen, Gang
    ONCOTARGET, 2016, 7 (03) : 3538 - 3547
  • [35] MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
    Liu, Zhaojian
    Liu, Jinsong
    Segura, Miguel F.
    Shao, Changshun
    Lee, Peng
    Gong, Yaoqin
    Hernando, Eva
    Wei, Jian-Jun
    JOURNAL OF PATHOLOGY, 2012, 228 (02) : 204 - 215
  • [36] Characteristics of 10-year survivors of high-grade serous ovarian carcinoma
    Dao, Fanny
    Schlappe, Brooke A.
    Tseng, Jill
    Lester, Jenny
    Nick, Alpa M.
    Lutgendorf, Susan K.
    McMeekin, Scott
    Coleman, Robert L.
    Moore, Kathleen N.
    Karlan, Beth Y.
    Sood, Anil K.
    Levine, Douglas A.
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 260 - 263
  • [37] Immunohistochemical expression and predictive value of PAX3 and FOXO1 proteins in high-grade serous ovarian carcinoma
    Tiric, Dejan
    Soldo, Dragan
    Tomic, Vajdana
    Penava, Nikolina
    Katic, Kristina
    Milkovicperisa, Marija
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 46 (03) : 74 - 83
  • [38] Assessment of lymph node metastases in patients with ovarian high-grade serous carcinoma: Incremental diagnostic value of dual-energy CT combined with morphologic parameters
    Zhang, Aining
    Shao, Wenhui
    Song, Jiacheng
    Zhai, Weiling
    Lin, Shushen
    Cheng, Wenjun
    Wu, Feiyun
    Chen, Ting
    EUROPEAN JOURNAL OF RADIOLOGY, 2025, 187
  • [39] Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma
    Mairinger, Elena
    Wessolly, Michael
    Buderath, Paul
    Borchert, Sabrina
    Henrich, Larissa
    Mach, Pawel
    Steinborn, Julia
    Kimming, Rainer
    Jasani, Bharat
    Schmid, Kurt Werner
    Bankfalvi, Agnes
    Mairinger, Fabian Dominik
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
    Hiramatsu, Kosuke
    Yoshino, Kiyoshi
    Serada, Satoshi
    Yoshihara, Kosuke
    Hori, Yumiko
    Fujimoto, Minoru
    Matsuzaki, Shinya
    Egawa-Takata, Tomomi
    Kobayashi, Eiji
    Ueda, Yutaka
    Morii, Eiichi
    Enomoto, Takayuki
    Naka, Tetsuji
    Kimura, Tadashi
    BRITISH JOURNAL OF CANCER, 2016, 114 (05) : 554 - 561